Pfizer, Valneva Lyme vaccine enters EMA review
Share
Pfizer (NYSE:PFE) and Valneva (NASDAQ:VALN) said the EMA validated their PF-07307405 Lyme vaccine application after Phase 3 efficacy exceeded 70%.
Pfizer (NYSE:PFE) and Valneva (NASDAQ:VALN) said the EMA validated their PF-07307405 Lyme vaccine application after Phase 3 efficacy exceeded 70%.
In a significant move for pharmaceutical transparency, the Bristol Myers Squibb-Pfizer Alliance announced that Eliquis® (apixaban), one of the world’s most widely prescribed blood thinners, will soon be available through Mark Cuban’s direct-to-consumer pharmacy.
Pfizer (NYSE:PFE) announced on June 8, 2026, that the U.S. Food and Drug Administration (FDA) has granted an expanded indication for HYMPAVZI® (marstacimab-hncq). The therapy is now approved for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and pediatric patients 6 years of age and older with hemophilia A or B, both with and without inhibitors.
Pfizer (NYSE:PFE) and Astellas announced today that the U.S. Food and Drug Administration (FDA) has accepted for Priority Review a supplemental Biologics License Application (sBLA) for the perioperative use of Padcev (enfortumab vedotin-ejfv) in combination with Keytruda (pembrolizumab).
Nina Trentmann, Senior Editor at Bloomberg News, discussed the recent appointment of Dave Denton, formerly Pfizer's CFO, as Nike's new Finance Chief. While some analysts have expressed concerns about Denton's lack of direct retail and apparel industry experience, Trentmann noted that for large companies like Nike and Pfizer, deep industry knowledge may be less critical than experience managing a complex, global business with a significant market capitalization and extensive supply chains. She speaks with Romaine Bostick & Katie Greifeld on "The Close."
Pfizer (NYSE:PFE) announced today that its Chief Financial Officer, Dave Denton, will depart the company on August 15, 2026, to accept a new position within the consumer goods industry.
_1431358_640x360_2505225795777-640x360.webp&w=3840&q=75)
